TN2010000348A1 - Methods and compositions using klotho-fgf fusion polypeptides - Google Patents

Methods and compositions using klotho-fgf fusion polypeptides

Info

Publication number
TN2010000348A1
TN2010000348A1 TNP2010000348A TN2010000348A TN2010000348A1 TN 2010000348 A1 TN2010000348 A1 TN 2010000348A1 TN P2010000348 A TNP2010000348 A TN P2010000348A TN 2010000348 A TN2010000348 A TN 2010000348A TN 2010000348 A1 TN2010000348 A1 TN 2010000348A1
Authority
TN
Tunisia
Prior art keywords
klotho
compositions
methods
fusion polypeptides
fgf fusion
Prior art date
Application number
TNP2010000348A
Other languages
French (fr)
Inventor
David Glass
Shou Ih Hu
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2009/050850 external-priority patent/WO2009095372A1/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TN2010000348A1 publication Critical patent/TN2010000348A1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention is directed to methods, kits and compositions for preventing or treating age-related conditions or metabolic disorders. The Klotho fusion polypeptides of the invention include at least a Klotho protein or an active fragment thereof. The Klotho fusion proteins are useful in the treatment and prevention of a variety of age-related conditions and metabolic disorders.
TNP2010000348A 2009-01-26 2010-07-23 Methods and compositions using klotho-fgf fusion polypeptides TN2010000348A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2009/050850 WO2009095372A1 (en) 2008-01-28 2009-01-26 Methods and compositions using klotho-fgf fusion polypeptides

Publications (1)

Publication Number Publication Date
TN2010000348A1 true TN2010000348A1 (en) 2011-12-29

Family

ID=55024480

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2010000348A TN2010000348A1 (en) 2009-01-26 2010-07-23 Methods and compositions using klotho-fgf fusion polypeptides

Country Status (1)

Country Link
TN (1) TN2010000348A1 (en)

Similar Documents

Publication Publication Date Title
MX2010008206A (en) Methods and compositions using klotho-fgf fusion polypeptides.
EA201170349A1 (en) MIF MODULATORS
MX2009012623A (en) Heterocyclic kinase modulators.
AU2011328009A8 (en) Compounds and methods for treating pain
EA201390506A1 (en) POLYPEPTIDES THAT BIND THE COMPONENT C5 OF THE HUMAN COMPLEX
WO2010130830A3 (en) Anti-sclerostin vhh and their use for treating bone diseases
EA201390803A1 (en) Bromodomain inhibitors and their use
MX2019001095A (en) Fibronectin based scaffold domain proteins that bind pcsk9.
TN2014000109A1 (en) Fusion proteins for treating metabolic disorders
MX2015002371A (en) Bivalent inhibitors of iap proteins and therapeutic methods using the same.
TW200833692A (en) Triazolopyridazine protein kinase modulators
WO2011134084A8 (en) Methods, compositions, and kits for the treatment of matrix mineralization disorders
WO2009089635A9 (en) Treating neurodegenerative diseases with progranulin (pgrn)
EA200870185A1 (en) COMBINATION OF ANG2 AND VEGF INHIBITORS
MX2013005639A (en) Methods of treating fgf21-associated disorders.
MX2014001372A (en) Pharmaceutical composition for treatment and/or prevention of pancreatic cancer.
MX350046B (en) Treatments for gastrointestinal disorders.
MX2010005909A (en) Combination of protein tyrosine phosphatase inhibitors and human growth hormone for the treatment of muscle atrophy and related disorders.
IN2012DN00908A (en)
NZ603570A (en) Biological materials related to her3
MY167232A (en) Polypeptides binding to human complement c5
MY167804A (en) Treatment of degenerative joint disease
MX2011011768A (en) Compositions and methods of use for binding molecules to dickkopf-1 or dickkopf-4 or both.
MX2012006430A (en) Combination preparations comprising a cytokine antagonist and corticosteroid.
MY160560A (en) Compositions and methods for treatment of kidney disorders